Rate of MMSE score change in Alzheimer's disease: Influence of education and vascular risk factors

Clinical Neurology and Neurosurgery

Volumn 111, Issue 4, 2009, Pages 327-330

  Roselli, Francesco ^a   Tartaglione, Bruno ^a   Federico, Francesco ^a   Lepore, Vito ^a   Defazio, Giovanni ^a   Livrea, Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Alzheimer's disease; Cognitive decline; Cognitive reserve; Education; MMSE; Progression rate

Indexed keywords

CHOLINESTERASE INHIBITOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; COGNITION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPERTENSION; MALE; MEDICAL RECORD REVIEW; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTOR VARIABLE; RATING SCALE; RISK FACTOR; SCHOOL; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COGNITION; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; EDUCATIONAL STATUS; FEMALE; HUMANS; HYPERTENSION; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 63449114793     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.10.006     Document Type: Article

References (41)

1. Adak S., Illouz K., Gorman W., Tandon R., Zimmerman E.A., Guariglia R., et al. Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology 63 (2004) 108-111
2. Bowler J.V., Munoz D.G., Merskey H., and Hachinski V. Factors affecting the age of onset and rate of progression of Alzheimer's disease. J Neurol Neurosurg Psychiatry 65 (1998) 184-190
3. Rascovsky K., Salmon D.P., Lipton A.M., Leverenz J.B., DeCarli C., Jagust W.J., et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology 65 (2005) 397-403
4. Scarmeas N., Albert S.M., Manly J.J., and Stern Y. Education and rate of cognitive decline in incident Alzheimer's disease. J Neurol Neurosurg Psychiatry 77 (2006) 308-316
5. Stern Y., Albert S., Tang M.X., and Tsai W.Y. Rate of memory decline in AD is related to education and occupation: cognitive reserve?. Neurology 53 (1999) 1942-1947
6. Storandt M., Grant E.A., Miller J.P., and Morris J.C. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 59 (2002) 1034-1041
7. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Mendes de Leon C.F., Arnold S.E., et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 60 (2003) 1909-1915
8. Haxby J.V., Raffaele K., Gillette J., Schapiro M.B., and Rapoport S.I. Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J Clin Exp Neuropsychol 14 (1992) 575-592
9. Filley C.M., Brownell H.H., and Albert M.L. Education provides no protection against Alzheimer's disease. Neurology 35 (1985) 1781-1784
10. Katzman R., Brown T., Thal L.J., Fuld P.A., Aronson M., Butters N., et al. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Ann Neurol 24 (1988) 384-389
11. Del Ser T., Hachinski V., Merskey H., and Munoz D.G. An autopsy-verified study of the effect of education on degenerative dementia. Brain 122 (1999) 2309-2319
12. Perneczky R., Drzezga A., Diehl-Schmid J., Schmid G., Wohlschläger A., Kars S., et al. Schooling mediates brain reserve in Alzheimer's disease: findings of FDG PET. J Neurol Neurosurg Psychiatry 77 (2006) 1060-1063
13. Scarmeas N., Zarahn E., Anderson K.E., Hilton J., Flynn J., Van Heertum R.L., et al. Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage 19 (2003) 1215-1227
14. Elkins J.S., Longstreth Jr. W.T., Manolio T.A., Newman A.B., Bhadelia R.A., and Johnston S.C. Education and the cognitive decline associated with MRI-defined brain infarct. Neurology 67 (2006) 435-440
15. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., and Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61 (2004) 661-666
16. Bellew K.M., Pigeon J.G., Stang P.E., Fleischman W., Gardner R.M., and Baker W.W. Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 18 (2004) 208-213
17. Bhargava D., Weiner M.F., Hynan L.S., Diaz-Arrastia R., and Lipton A.M. Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J Geriatr Psychiatry Neurol 19 (2006) 78-82
18. Haan M.N., Shemanski L., Jagust W.J., Manolio T.A., and Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282 (1999) 40-46
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. revised (1994), APA, Washington, DC
20. Knopman D.S., DeKosky S.T., Cummings J.L., Chui H., Corey-Bloom J., Relkin N., et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the American academy of neurology. Neurology 56 (2001) 1143-1153
21. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
22. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
23. Musicco M., Caltagirone C., Sorbi S., Bonavita V., and Dementia Study Group of the Italian Neurological Society Dementia Study Group of the Italian Neurological Society. Italian Neurological Society guidelines for the diagnosis of dementia: revision I. Neurol Sci 25 (2004) 154-182
24. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51 (1998) 1546-1554
25. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., and Cummings J.L. DeKosky ST Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56 (2001) 1133-1142
26. Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 (1993) 250-260
27. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43 (1993) 2412-2414
28. WHO Guidelines Subcommittee. International Society of Hypertension: guidelines for the management of hypertension. J Hypertens 17 (1999) 151-183
29. Moritz D.J., Fox P.J., and Luscombe F.A. Kraemer HC Neurological and psychiatric predictors of mortality in patients with Alzheimer disease in California. Arch Neurol 54 (1997) 878-885
30. Wilson R.S., Li Y., Aggarwal N.T., Barnes L.L., McCann J.J., Gilley D.W., et al. Education and the course of cognitive decline in Alzheimer disease. Neurology 63 (2004) 1198-1202
31. Perneczky R., Drzezga A., Diehl-Schmid J., Li Y., and Kurz A. Gender differences in brain reserve: an (18)F-FDG PET study in Alzheimer's disease. J Neurol 254 (2007) 1395-1400
32. Barnes L.L., Wilson R.S., Bienias J.L., Schneider J.A., Evans D.A., and Bennett D.A. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62 (2005) 685-691
33. Courtney C., Farrell D., Gray R., Hills R., Lynch L., Sellwood E., et al., AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 363 (2004) 2105-2115
34. Trinh N.H., Hoblyn J., Mohanty S., and Yaffe K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA 289 (2003) 210-216
35. Mendiondo M.S., Ashford J.W., and Kryscio R.J. Schmitt Modelling mini mental state examination changes in Alzheimer's disease. Stat Med 19 (2000) 1607-1616
36. Kukull W.A., Larson E.B., Reifler B.V., Lampe T.H., Yerby M.S., and Hughes J.P. The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology 40 (1990) 1364-1369
37. Farrer L.A., Cupples L.A., Blackburn S., Kiely D.K., Auerbach S., Growdon J.H., et al. Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study. Neurology 44 (1994) 652-656
38. Mielke M.M., Rosenberg P.B., Tschanz J., Cook L., Corcoran C., Hayden K.M., Norton M., Rabins P.V., Green R.C., Welsh-Bohmer K.A., Breitner J.C., Munger R., and Lyketsos C.G. Vascular factors predict rate of progression in Alzheimer disease. Neurology 69 (2007) 1850-1858
39. Bunce D., Fratiglioni L., Small B.J., Winblad B., and Bäckman L. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology 63 (2004) 816-821
40. Sluimer J.D., van der Flier W.M., Karas G.B., Fox N.C., Scheltens P., Barkhof F., et al. Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology 248 (2008) 590-598
41. Ridha B.H., Anderson V.M., Barnes J., Boyes R.G., Price S.L., Rossor M.N., et al. MRI and cognitive measures in Alzheimer disease: comparison of markers of progression. J Neurol 255 (2008) 567-574